Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • New Delhi

    Tag: new delhi

    You Searched For "New Delhi"
    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Zydus Cadila gets USFDA nod for Phentermine Hydrochloride orally disintegrating tablets

    Medical Dialogues Bureau26 April 2019 8:59 AM IST
    Phentermine Hydrochloride orally disintegrating tablets is used together with diet and exercise to treat obesity (overweight) in people with risk...
    All medical devices sold in India to be CDSCO certified: What is Means

    All medical devices sold in India to be CDSCO certified: What is Means

    Meghna A Singhania18 April 2019 2:59 PM IST
    Once this notification comes into effect, the manufacture and sale of all medical devices would have to be certified by the Central Drugs Standard...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

    Farhat Nasim18 April 2019 10:00 AM IST
    Acetazolamide injection is a generic version of Diamox for injection.New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod...
    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Farhat Nasim17 April 2019 9:45 AM IST
    Zydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Garima16 April 2019 9:40 AM IST
    Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
    Alcon sees India as key growth engine for business; to focus on surgical, vision care, dry eye portfolios

    Alcon sees India as key growth engine for business; to focus on surgical, vision care, dry eye portfolios

    Medical Dialogues Bureau11 April 2019 9:05 AM IST
    With the completion of the spin-off, Alcon will become the largest eye care devices company in the world, he added.New Delhi: Global eye care major...
    Cipla gets 8 USFDA observations for Kurkumbh plant

    Cipla gets 8 USFDA observations for Kurkumbh plant

    Farhat Nasim1 April 2019 9:55 AM IST
    The inspection covered three units at the plant. Post the conclusion of the inspection, the company received 8 GMP observations. The company also...
    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Lupin, Aurobindo Pharma recalls multiple lots of BP drug including VALSARTAN

    Farhat Nasim1 April 2019 9:50 AM IST
    Aurobindo Pharma is also recalling certain lots of Amlodipine and Valsartan Tablets USP 10mg/160mg in 30 count bottles for CGMP deviations.New Delhi:...
    Dr Reddy

    Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction

    Farhat Nasim28 March 2019 12:06 PM IST
    Dr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
    People run from pillar to post to get insurance claim from companies: Delhi consumer commission

    People run from pillar to post to get insurance claim from companies: Delhi consumer commission

    Farhat Nasim21 March 2019 9:55 AM IST
    The Consumer Commission said medical insurance is primarily obtained for the purpose of unforeseen medical conditions and so long as there has been no...
    Lupin Somerset facility gets OAI letter from USFDA

    Lupin Somerset facility gets OAI letter from USFDA

    Farhat Nasim18 March 2019 9:25 AM IST
    "The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok